Effect of Time-of-Day Nivolumab and Stereotactic Body Radiotherapy in Metastatic Head and Neck Squamous Cell Carcinoma: A Secondary Analysis of a Prospective Randomized Trial

被引：0
|
作者：
Janopaul-Naylor, J. [1 ]
Boe, L. A. [2 ]
Yu, Y. [1 ]
Sherman, E.
Pfister, D. G. [3 ]
Lee, N. Y. [1 ]
McBride, S. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med Oncol, New York, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3667
引用
收藏
页码：E761 / E761
页数：1
相关论文
共 50 条
  • [1] Effect of time-of-day nivolumab and stereotactic body radiotherapy in metastatic head and neck squamous cell carcinoma: A secondary analysis of a prospective randomized trial
    Janopaul-Naylor, James R.
    Boe, Lillian
    Yu, Yao
    Sherman, Eric J.
    Pfister, David G.
    Lee, Nancy Y.
    McBride, Sean
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (09): : 2292 - 2300
  • [2] Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma
    McBride, Sean
    Sherman, Eric
    Tsai, C. Jillian
    Baxi, Shrujal
    Aghalar, Jahan
    Eng, Juliana
    Zhi, Wanqing Iris
    McFarland, Daniel
    Michel, Loren Scott
    Young, Robert
    Lefkowitz, Robert
    Spielsinger, Daniel
    Zhang, Zhigang
    Flynn, Jessica
    Dunn, Lara
    Ho, Alan
    Riaz, Nadeem
    Pfister, David
    Lee, Nancy
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (01) : 30 - +
  • [3] A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC).
    McBride, Sean Matthew
    Sherman, Eric Jeffrey
    Tsai, C. Jillian
    Baxi, Shrujal S.
    Aghalar, Jahan
    Eng, Juliana
    Zhi, Wanqing Iris
    McFarland, Daniel Curtis
    Michel, Loren S.
    Spielsinger, Daniel
    Zhang, Zhigang
    Flynn, Jessica
    Dunn, Lara
    Ho, Alan Loh
    Riaz, Nadeem
    Pfister, David G.
    Lee, Nancy Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Impacts of time-of-day of nivolumab infusion on treatment efficacy for patients with head and neck squamous cell carcinoma
    Tsunoki, T.
    Kadowaki, S.
    Mizuno, T.
    Ishizuka, Y.
    Sakakida, T.
    Narita, Y.
    Honda, K.
    Masuishi, T.
    Taniguchi, H.
    Ando, M.
    Muro, K.
    Hanai, N.
    ANNALS OF ONCOLOGY, 2024, 35
  • [5] Biomarker predictors of outcome from a randomized trial of nivolumab plus /- stereotactic body radiotherapy (SBRT) in metastatic (M1) head and neck squamous cell carcinoma (HNSCC).
    McBride, Sean Matthew
    Lee, Nancy Y.
    Pfister, David G.
    Sherman, Eric Jeffrey
    Tsai, C. Jillian
    Aghalar, Jahan
    Eng, Juliana
    Zhi, Wanqing Iris
    McFarland, Daniel Curtis
    Michel, Loren S.
    Dunn, Lara
    Ho, Alan Loh
    Riaz, Nadeem
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] CAMRESBRT: Randomized Phase II Trial of Camrelizumab with Stereotactic Body Radiotherapy vs. Camrelizumab Alone in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Lei, Q.
    Wang, Y.
    Sui, J.
    Luo, Q.
    Jin, F.
    Long, B.
    Shu, X.
    Li, S.
    Huang, L.
    Zhong, M.
    Mao, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E282 - E282
  • [7] Radiotherapy breathing for and neck alone or combined with carbogen squamous cell carcinoma of the head - A prospective, randomized trial
    Mendenhall, WM
    Morris, CG
    Amdur, RJ
    Mendenhall, NP
    Siemann, DW
    CANCER, 2005, 104 (02) : 332 - 337
  • [8] Reirradiation and stereotactic body radiotherapy for recurrent or second primary squamous cell carcinoma of the head and neck
    Mahmoud, O. M.
    Koyfman, S. A.
    JOURNAL OF RADIATION ONCOLOGY, 2015, 4 (02) : 117 - 128
  • [9] Effect of performance status on the therapeutic effect of nivolumab in recurrent or metastatic squamous cell carcinoma of the head and neck
    Nishimura, Ari
    Ishida, Chie
    Tanaka, Akihisa
    Kimura, Takahiro
    Yoshii, Yumi
    Uemura, Hirokazu
    Takeda, Masayuki
    Kitahara, Tadashi
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2024, : 2071 - 2076
  • [10] STEREOTACTIC BODY RADIOTHERAPY FOR RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK: RESULTS OF A PHASE I DOSE-ESCALATION TRIAL
    Heron, Dwight E.
    Ferris, Robert L.
    Karamouzis, Michalls
    Andrade, Regiane S.
    Deeb, Erin L.
    Burton, Steven
    Gooding, William E.
    Branstetter, Barton F.
    Mountz, James M.
    Johnson, Jonas T.
    Argiris, Athanassios
    Grandis, Jennifer R.
    Lai, Stephen Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (05): : 1493 - 1500
12345